Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 65.23% is 34% above its 5-year average of 48.81%, near the high end of its 5-year range (38.08%–65.23%).
As of the fiscal period ended Tuesday, March 31, 2026. 26.08% above its 12-month average of 51.74%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
65.23%
EBITDA MARGIN AVG TTM
51.74%
EBITDA MARGIN AVG 3Y
49.87%
EBITDA MARGIN AVG 5Y
49.34%
EBITDA MARGIN AVG 10Y
48.48%
EBITDA MARGIN AVG 15Y
45.43%
EBITDA MARGIN AVG 20Y
41.84%
CURRENT VS TTM AVG
+26.08%
CURRENT VS 3Y AVG
+30.79%
CURRENT VS 5Y AVG
+32.20%
CURRENT VS 10Y AVG
+34.55%
CURRENT VS 15Y AVG
+43.57%
CURRENT VS 20Y AVG
+55.90%
Novo Nordisk A/S
Market Cap
$196.77B
EBITDA Margin
65.23%
TTM Avg
51.74%
3Y Avg
49.87%
5Y Avg
49.34%
Market Cap
$209.87B
EBITDA Margin
24.44%
TTM Avg
24.78%
3Y Avg
25.35%
5Y Avg
27.67%
Market Cap
$182.49B
EBITDA Margin
24.35%
TTM Avg
24.15%
3Y Avg
24.77%
5Y Avg
25.59%
Market Cap
$167.92B
EBITDA Margin
49.12%
TTM Avg
32.26%
3Y Avg
34.27%
5Y Avg
33.90%
Market Cap
$136.93B
EBITDA Margin
30.87%
TTM Avg
31.21%
3Y Avg
32.47%
5Y Avg
31.98%
Market Cap
$134.59B
EBITDA Margin
36.80%
TTM Avg
38.33%
3Y Avg
39.88%
5Y Avg
39.69%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novo Nordisk A/S (NVO) | $196.77B | 65.23% | 51.74% | 49.87% | 49.34% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $209.87B | 24.44% | 24.78% | 25.35% | 27.67% |
| Amgen Inc. (AMGN)vs › | $210.50B | 43.12% | 40.78% | 43.34% | 44.32% |
| Abbott Laboratories (ABT)vs › | $182.49B | 24.35% | 24.15% | 24.77% | 25.59% |
| Gilead Sciences, Inc. (GILD)vs › | $167.92B | 49.12% | 32.26% | 34.27% | 33.90% |
| AstraZeneca PLC (AZN)vs › | $241.35B | 33.16% | 30.52% | 27.50% | 25.68% |
| Pfizer Inc. (PFE)vs › | $144.82B | 32.51% | 34.72% | 32.84% | 32.73% |
| Danaher Corporation (DHR)vs › | $136.93B | 30.87% | 31.21% | 32.47% | 31.98% |
| Bristol-Myers Squibb Company (BMY)vs › | $134.59B | 36.80% | 38.33% | 39.88% | 39.69% |
| CVS Health Corp. (CVS)vs › | $133.23B | 3.73% | 3.63% | 4.02% | 4.83% |
Gross Margin
81.8%
EBITDA Margin
65.2%
Operating Margin
45.2%
Net Margin
37.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 65.23% |
| 2025-12-31 | 47.13% |
| 2025-09-30 | 41.93% |
| 2025-06-30 | 49.81% |
| 2025-03-31 | 54.58% |
| 2024-12-31 | 48.94% |
| 2024-09-30 | 50.44% |
| 2024-06-30 | 51.10% |
| 2024-03-31 | 53.19% |
| 2023-12-31 | 45.18% |
| 2023-09-30 | 50.12% |
| 2023-06-30 | 48.00% |
| 2023-03-31 | 50.08% |
| 2022-12-31 | 38.08% |
| 2022-09-30 | 48.78% |
| 2022-06-30 | 48.53% |
| 2022-03-31 | 49.48% |
| 2021-12-31 | 41.00% |
| 2021-09-30 | 46.59% |
| 2021-06-30 | 48.41% |
| 2021-03-31 | 48.39% |
| 2020-12-31 | 39.07% |
| 2020-09-30 | 48.30% |
| 2020-06-30 | 49.98% |
| 2020-03-31 | 51.33% |
| 2019-12-31 | 40.94% |
| 2019-09-30 | 49.59% |
| 2019-06-30 | 48.48% |
| 2019-03-31 | 52.22% |
| 2018-12-31 | 41.79% |
| 2018-09-30 | 45.37% |
| 2018-06-30 | 47.33% |
| 2018-03-31 | 48.94% |
| 2017-12-31 | 39.13% |
| 2017-09-30 | 47.91% |
| 2017-06-30 | 49.76% |
| 2017-03-31 | 49.90% |
| 2016-12-31 | 41.67% |
| 2016-09-30 | 47.78% |
| 2016-06-30 | 48.12% |
| 2016-03-31 | 47.53% |
| 2015-12-31 | 42.04% |
| 2015-09-30 | 47.08% |
| 2015-06-30 | 48.52% |
| 2015-03-31 | 57.62% |
| 2014-12-31 | 40.37% |
| 2014-09-30 | 43.83% |
| 2014-06-30 | 43.46% |
| 2014-03-31 | 42.72% |
| 2013-12-31 | 36.87% |
| 2013-09-30 | 42.10% |
| 2013-06-30 | 43.32% |
| 2013-03-31 | 41.30% |
| 2012-12-31 | 39.15% |
| 2012-09-30 | 39.63% |
| 2012-06-30 | 39.31% |
| 2012-03-31 | 35.97% |
| 2011-12-31 | 33.56% |
| 2011-09-30 | 37.65% |
| 2011-06-30 | 38.06% |
| 2011-03-31 | 38.38% |
| 2010-12-31 | 31.18% |
| 2010-09-30 | 36.77% |
| 2010-06-30 | 36.61% |
| 2010-03-31 | 36.30% |
| 2009-12-31 | 24.64% |
| 2009-09-30 | 35.72% |
| 2009-06-30 | 35.56% |
| 2009-03-31 | 35.34% |
| 2008-12-31 | 26.83% |
| 2008-09-30 | 29.56% |
| 2008-06-30 | 25.63% |
| 2008-03-31 | 26.65% |
| 2007-12-31 | 10.36% |
| 2007-09-30 | 25.52% |
| 2007-06-30 | 26.60% |
| 2007-03-31 | 23.71% |
| 2006-12-31 | 20.06% |
| 2006-09-30 | 26.13% |
| 2006-06-30 | 27.05% |
| 2006-03-31 | 26.20% |
| 2005-12-31 | 20.39% |
| 2005-09-30 | 26.25% |
| 2005-06-30 | 28.27% |
| 2005-03-31 | 20.81% |
| 2004-12-31 | 22.94% |
| 2004-09-30 | 23.62% |
| 2004-06-30 | 26.28% |
| 2004-03-31 | 23.06% |
| 2003-12-31 | 25.13% |
| 2003-09-30 | 24.38% |
| 2003-06-30 | 24.80% |
| 2003-03-31 | 21.65% |
| 2002-12-31 | -187.05% |
| 2002-09-30 | 100.00% |
| 2002-06-30 | 100.00% |
